Facebook
Twitter
LinkedIn
ForwardDelaware SUPPORT Office Based Opioid Treatment (OBOT) Fellowship - Clinical Provider Track: May 26, 2021
Jointly Provided by the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) and the American Institutes for Research (AIR).
ELEMENTS OF COMPETENCE
This CE activity has been designed to improve learner competence and performance and focuses on the American Board of Medical Specialties’ areas of patient care and procedural skills and medical knowledge.
This activity focuses on the Interprofessional competencies of roles/responsibilities, interprofessional communication, and teams/teamwork.
This activity also focuses on the Institute of Medicine competencies of provide patient-centered care, work in interdisciplinary teams and employ evidence-based practice.
Intended Audience
This program is intended for clinicians on identification, diagnosis and treatment of opioid use disorder.
Learning Objectives
At the conclusion of the activity, the clinical healthcare team members will be able to:
- Screen for substance use using a validated clinical assessment tool
- Diagnose OUD based on DSM-5 criteria.
- Initiate buprenorphine safely to the patient.
- Identify strategies to minimize the likelihood of precipitated withdrawal.
- Plan patient-centered, guideline appropriate follow-up to minimize return to use.
POLICY ON DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests* in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s).
For this educational activity, all conflicts of interest have been resolved and detailed disclosures are listed below:
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/ |
Maliha Ali, MBBS, DrPH | Committee Member | No relevant financial relationships to disclose | No |
Anika Alvanzo, MD | Speaker/Author | American Society of Addiction Medicine (Fiduciary Officer), Maryland Department of Health and Mental Hygiene (Contractor); Pyramid Healthcare, Inc. (Employment) | No |
Terese Bailey, BS | Planner | No relevant financial relationships to disclose | No |
Kathryn Basques, MSW, MSN, APN, PMHMP-BC | Speaker/Author | No relevant financial relationships to disclose | Yes |
Amanda Brooks, LCSW, CADC | Speaker/Author | No relevant financial relationships to disclose | No |
Megan Buresh, MD | Speaker/Author | American Society of Addiction Medicine (Contractor) | No |
Quy Nhi Cap, MPH | Committee Member & Planner | No relevant financial relationships to disclose | No |
Nicole Gastala, MD | Speaker/Author | No relevant financial relationships to disclose | No |
Daniel Harwell, MS | Committee Member | No relevant financial relationships to disclose | No |
Terry Horton, MD, FACP, DABAM | Speaker/Author | Masimo (Consultant and Advisory Group Member) | No |
Sarah Mossburg, BSN, MS, PhD | Committee Member | No relevant financial relationships to disclose | No |
Elizabeth Salsbury-Afshar, MD, MPH, FAAFP, FACPM, DFASAM | Committee Member, Speaker/Author, Content Reviewer | No relevant financial relationships to disclose | No |
Mishka Terplan, MD, MPH, FACOG, DFASAM | Committee Member, Speaker/Author, Content Reviewer | No relevant financial relationships to disclose | No |
Claire Viscione, BS | Committee Member | No relevant financial relationships to disclose | No |
Krishna Winfrey, BS | Committee Member | No relevant financial relationships to disclose | No |
*The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
 | In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison ICEP and American Institutes on Research (AIR). The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.0 ANCC contact hours.
Continuing Education Units (CEUs)
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 CEUs or 1.0 hour.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 University of Wisconsin–Madison Continuing Education Hours
- 1.00 Approved for AMA PRA Category 1 Credit™